KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Teladoc Health (TDOC) Shares Outstanding (2016 - 2026)

Teladoc Health's Shares Outstanding history spans 14 years, with the latest figure at $180.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 2.9% to $180.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $180.4 million, a 2.9% increase, with the full-year FY2025 number at $178.3 million, up 2.83% from a year prior.
  • Shares Outstanding hit $180.4 million in Q1 2026 for Teladoc Health, up from $178.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for TDOC hit a ceiling of $180.4 million in Q1 2026 and a floor of $161.4 million in Q1 2022.
  • Historically, Shares Outstanding has averaged $169.6 million across 5 years, with a median of $169.3 million in 2024.
  • The widest YoY moves for Shares Outstanding: up 4.55% in 2022, down 1.36% in 2022.
  • Tracing TDOC's Shares Outstanding over 5 years: stood at $162.8 million in 2022, then rose by 2.34% to $166.7 million in 2023, then rose by 4.05% to $173.4 million in 2024, then rose by 2.83% to $178.3 million in 2025, then rose by 1.19% to $180.4 million in 2026.
  • Business Quant data shows Shares Outstanding for TDOC at $180.4 million in Q1 2026, $178.3 million in Q4 2025, and $177.3 million in Q3 2025.